OPKO Health (FRA:XCY) COGS-to-Revenue : 0.75 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is OPKO Health COGS-to-Revenue?

OPKO Health's Cost of Goods Sold for the three months ended in Dec. 2023 was €125.8 Mil. Its Revenue for the three months ended in Dec. 2023 was €166.8 Mil.

OPKO Health's COGS to Revenue for the three months ended in Dec. 2023 was 0.75.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. OPKO Health's Gross Margin % for the three months ended in Dec. 2023 was 24.58%.

OPKO Health COGS-to-Revenue Historical Data

The historical data trend for OPKO Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health COGS-to-Revenue Chart

OPKO Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.63

0.62

0.67

0.71

0.63

OPKO Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.70	0.58	0.52	0.73	0.75

OPKO Health COGS-to-Revenue Calculation

OPKO Health's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	500.103	/	791.825
	=	0.63

OPKO Health's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	125.81	/	166.806
	=	0.75

OPKO Health (FRA:XCY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

OPKO Health's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	125.81 / 166.806
	=	24.58 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

OPKO Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of OPKO Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OPKO Health (FRA:XCY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (FRA:XCY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

OPK:USA OPK:Mexico OPK:Israel XCY:Germany

Address

4400 Biscayne Boulevard, Miami, FL, USA, 33137

Website

https://www.opko.com

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

OPKO Health (FRA:XCY) Headlines

No Headlines